Cytokines as Predictive Factors of Response to Somatostatin Analogues in Patients with Neuroendocrine Tumour Abstract #1770

Introduction: The somatostatin analogues are a major therapeutic advance in neuroendocrine tumor (NET) treatment and have multiple modulatory effects on the immune system.
Aim(s): The aim of this study was to evaluate the expression of several cytokines, at baseline and after administration of lanreotide (lan), in NET patients and NET cell lines.
Materials and methods: Ten NET patients were enrolled: 6 gastro-entero-pancreatic (GEP) NET, 2 bronchial carcinoids (BC), 2 breast NET. The expression of Interleukin 2, 4, 6, 10, TNF-α and IFN-γ were assessed on serum samples at T0 and after 10 up to 180 days of lan treatment, by cytometry. Lan effect on NET cell lines viability was evaluated by MTT and IL-6, IL-10 and TNF-α level by Western-Blotting.
Conference: 14th Annual ENETS conference 2017 (2017)
Category: Basic Science - Signaling pathways, receptors, biomarkers
Presenting Author: Concetta Sciammarella

To read results and conclusion, please login ...

Further abstracts you may be interested in

No result